Literature DB >> 14523111

Identification and characterization of a fibronectin-binding protein from Clostridium difficile.

Claire Hennequin1, Claire Janoir, Marie-Claude Barc, Anne Collignon, Tuomo Karjalainen.   

Abstract

A 68 kDa fibronectin-binding protein (Fbp68) from Clostridium difficile displaying significant homology to several established or putative Fbps from other bacteria was identified. The one-copy gene is highly conserved in C. difficile isolates. Fbp68 was expressed in Escherichia coli in fusion with glutathione S-transferase; the fusion protein and the native Fbp68 were purified. Immunoblot analysis and cell fractionation experiments revealed that Fbp68 is present on the surface of the bacteria. Far-immuno dot-blotting demonstrated that Fbp68 was capable of fixing fibronectin. Indirect immunofluorescence and ELISA were employed to demonstrate that C. difficile could bind both soluble and immobilized fibronectin. With competitive adherence inhibition assays it was shown that antibodies raised against Fbp68 partially inhibited attachment of C. difficile to fibronectin and Vero cells. Furthermore, Vero cells could fix purified membrane-immobilized Fbp68. Thus Fbp68 appears to be one of the several adhesins identified to date in C. difficile.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14523111     DOI: 10.1099/mic.0.26145-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  37 in total

Review 1.  Adhesion of anaerobic periodontal pathogens to extracellular matrix proteins.

Authors:  Andressa Temperine de Oliveira Marre; Regina M C P Domingues; Leandro A Lobo
Journal:  Braz J Microbiol       Date:  2020-06-17       Impact factor: 2.476

2.  Identification of a genetic locus responsible for antimicrobial peptide resistance in Clostridium difficile.

Authors:  Shonna M McBride; Abraham L Sonenshein
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

Review 3.  Cyclic diguanylate signaling in Gram-positive bacteria.

Authors:  Erin B Purcell; Rita Tamayo
Journal:  FEMS Microbiol Rev       Date:  2016-06-26       Impact factor: 16.408

Review 4.  Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response.

Authors:  Gayatri Vedantam; Andrew Clark; Michele Chu; Rebecca McQuade; Michael Mallozzi; V K Viswanathan
Journal:  Gut Microbes       Date:  2012-03-01

5.  Human Clostridium difficile infection: altered mucus production and composition.

Authors:  Melinda A Engevik; Mary Beth Yacyshyn; Kristen A Engevik; Jiang Wang; Benjamin Darien; Daniel J Hassett; Bruce R Yacyshyn; Roger T Worrell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-31       Impact factor: 4.052

6.  The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?

Authors:  Justyna Bien; Vindhya Palagani; Przemyslaw Bozko
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

Review 7.  Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.

Authors:  Milena M Awad; Priscilla A Johanesen; Glen P Carter; Edward Rose; Dena Lyras
Journal:  Gut Microbes       Date:  2014

8.  Clostridium difficile toxin CDT hijacks microtubule organization and reroutes vesicle traffic to increase pathogen adherence.

Authors:  Carsten Schwan; Anna S Kruppke; Thilo Nölke; Lucas Schumacher; Friedrich Koch-Nolte; Mikhail Kudryashev; Henning Stahlberg; Klaus Aktories
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

9.  Type IV Pili Promote Clostridium difficile Adherence and Persistence in a Mouse Model of Infection.

Authors:  Robert W McKee; Naira Aleksanyan; Elizabeth M Garrett; Rita Tamayo
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

10.  A novel genetic switch controls phase variable expression of CwpV, a Clostridium difficile cell wall protein.

Authors:  Jenny E Emerson; Catherine B Reynolds; Robert P Fagan; Helen A Shaw; David Goulding; Neil F Fairweather
Journal:  Mol Microbiol       Date:  2009-07-28       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.